Procept wins FDA clearance for updated prostate surgery robot

Procept Biorobotics has added AI capabilities and switched to a single-use scope to support mass-market adoption.

By Nick Paul Taylor • Aug. 22, 2024

Zoll to buy Vyaire’s ventilator business with $37M auction bid

Vyaire Medical held a virtual auction of assets after filing for Chapter 11 bankruptcy protection in June.

By Nick Paul Taylor • Aug. 21, 2024

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

FDA’s plan to expand device surveillance faces challenges, GAO finds

Funding issues and limited use of unique device identifiers are hurdles to expanding an FDA system to monitor medical device safety, the federal watchdog said.

By Nick Paul Taylor • Aug. 21, 2024

Masimo’s consumer audio brands attract more suitors

Negotiations with a potential joint venture partner will continue while Masimo initiates discussions with new parties that have expressed interest in the consumer audio business.

By Susan Kelly • Aug. 21, 2024

J&J to buy heart failure implant maker V-Wave for up to $1.7B

J&J has agreed to pay $600 million upfront for the private company as it works to expand its portfolio of cardiovascular devices.

By Susan Kelly • Aug. 20, 2024

Edwards continues M&A spree with Genesis’ TAVR tech

Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech.

By Susan Kelly • Aug. 19, 2024

Histosonics raises $102M for noninvasive treatment to destroy tumors

Using sound waves to break down tumor tissue can offer patients with liver cancer an alternative to surgery, radiation and chemotherapy.

By Susan Kelly • Aug. 19, 2024

Biden pledges $150M for medical tech to improve cancer surgery

Awards include funding for microscopy and imaging tools to help surgeons ensure all cancer is removed during a procedure.

By Elise Reuter • Aug. 16, 2024

Stereotaxis earns CE mark for new surgical robot

CEO David Fischel said the platform, called GenesisX, is designed to address challenges hospitals have faced when installing the company’s earlier robotic systems.

By Susan Kelly • Aug. 15, 2024

Tandem warns iPhone app still draining insulin pump batteries

Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected shutdowns.

By Elise Reuter • Aug. 15, 2024

Neuronetics inks Greenbrook merger to acquire treatment centers

William Blair analysts said the deal changes Neuronetics’ profile “from device-centric to a device-service business operating brick-and-mortar facilities.” 

By Nick Paul Taylor • Aug. 15, 2024

Otsuka Precision Health launches first digital therapeutic for depression

Intended to supplement medications, the six-week, app-based treatment will cost $50 on a cash-pay basis.

By Elise Reuter • Aug. 14, 2024

Globus receives warning letter over spine navigation robot

The FDA said Globus delayed reporting complaints about misplaced screws, despite information that “reasonably suggests” the Excelsius GPS system malfunctioned.

By Nick Paul Taylor • Aug. 14, 2024

Baxter agrees to sell kidney care unit to Carlyle for $3.8B

Selling the business, called Vantive, rather than spinning it off, should maximize shareholder value and give Baxter more flexibility to pursue other growth opportunities, the company said.

By Susan Kelly • Aug. 13, 2024

Medtronic wins FDA approval for asleep deep brain stimulation

Medtronic said Monday it is the first company to receive FDA approval to offer DBS surgery while a patient is asleep or awake.

By Nick Paul Taylor • Aug. 13, 2024

Breas Medical flags risk of formaldehyde exposure in ventilators

Testing showed the potential for short-term exposure to elevated levels of formaldehyde under specific conditions.

By Nick Paul Taylor • Aug. 12, 2024

Solventum raises earnings forecast after first independent quarter

Four months after separating from 3M, CEO Bryan Hanson told investors on Solventum’s first earnings call that “a lot could have gone wrong, and it didn’t.”

By Elise Reuter • Aug. 9, 2024

Smiths Medical recalls infusion pumps over software issues

The devices may fail to emit alarms, have unresponsive stop and power keys, and reveal passwords.

By Nick Paul Taylor • Aug. 9, 2024

Axogen names ex-Abbott exec Michael Dale as CEO

Dale will replace Karen Zaderej, who is leaving the provider of peripheral nerve injury devices after 14 years as CEO.

By Nick Paul Taylor • Aug. 9, 2024

Zimmer to buy surgical navigation company Orthogrid

CEO Ivan Tornos said Zimmer hopes to grow its market share in hip procedures with the purchase. He also shared an update on the company’s new shoulder surgical robot.

By Elise Reuter • Aug. 8, 2024

CMS finalizes notice on Medicare coverage for breakthrough devices

Through the new pathway, called Transitional Coverage for Emerging Technologies, the CMS will consider five medical device candidates yearly for national coverage.

By Elise Reuter • Aug. 8, 2024

Nevro considers sale as competition for pain market ramps up

CEO Kevin Thornal told investors Nevro felt “an urgency” to respond to a market that is being reshaped by direct and indirect competition.

By Nick Paul Taylor • Aug. 8, 2024

Abbott, Medtronic partner on diabetes tech

Abbott will develop a glucose sensor that can only connect with Medtronic's insulin delivery technology.

By Elise Reuter • Aug. 7, 2024

Henry Schein’s slow recovery from cyber incident hits Q2 results

William Blair analysts said the “lingering impacts from the cyberattack are somewhat surprising.”

By Nick Paul Taylor • Aug. 7, 2024

Medtronic recalls nerve monitoring system linked to 10 injuries

Medtronic has asked users to be aware the devices may not alert when on a nerve, which could lead to injuries during surgery.

By Nick Paul Taylor • Aug. 7, 2024